Assessment of Immunogenicity, Safety and Reactogenicity of a Booster Dose of Various COVID-19 Vaccine Platforms in Individuals Primed With Several Regimes.
Clinical trial NCT05812586 · UNKNOWN
Trial details
- NCT number
- NCT05812586
- Sponsor
- D'Or Institute for Research and Education
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-14
- Primary completion
- 2023-06-01
- Enrollment
- 760
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.